Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer. [electronic resource]
Producer: 20040123Description: 355-62 p. digitalISSN:- 1357-0560
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cisplatin -- therapeutic use
- Deoxycytidine -- analogs & derivatives
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Proto-Oncogene Proteins c-bcl-2 -- drug effects
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- Receptors, Tumor Necrosis Factor -- drug effects
- Survival Rate
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.